thumbnail image
  • SCIENCE
  • CLINICAL TRIALS
  • PARTNERS 
    • PHARMA
    • PAYORS
    • HEALTH SYSTEMS
  • NEWS
  • OUR COMPANY 
    • AmDTx
    • OUR TEAM
    • CAREERS
  • CONTACT US
  • …  
    • SCIENCE
    • CLINICAL TRIALS
    • PARTNERS 
      • PHARMA
      • PAYORS
      • HEALTH SYSTEMS
    • NEWS
    • OUR COMPANY 
      • AmDTx
      • OUR TEAM
      • CAREERS
    • CONTACT US
    • SCIENCE
    • CLINICAL TRIALS
    • PARTNERS 
      • PHARMA
      • PAYORS
      • HEALTH SYSTEMS
    • NEWS
    • OUR COMPANY 
      • AmDTx
      • OUR TEAM
      • CAREERS
    • CONTACT US
    • …  
      • SCIENCE
      • CLINICAL TRIALS
      • PARTNERS 
        • PHARMA
        • PAYORS
        • HEALTH SYSTEMS
      • NEWS
      • OUR COMPANY 
        • AmDTx
        • OUR TEAM
        • CAREERS
      • CONTACT US
      • SCIENCE
      • CLINICAL TRIALS
      • PARTNERS
        • PHARMA
        • PAYORS
        • HEALTH SYSTEMS
      • NEWS
      • OUR COMPANY
        • AmDTx
        • OUR TEAM
          • OUR TEAM
          • CHIEF EXECUTIVE OFFICER
          • CHIEF TECHNOLOGY OFFICER
          • CHIEF OF CONTENT
          • CHIEF FINANCIAL OFFICER
          • VP PHARMACEUTICALS
          • ASSISTANT TO THE CEO
        • CAREERS
      • CONTACT US
        • Pharma

           

          Digitally-enabled pharmacotherapy, theragnostics and mental health endpoints.

           

          The greatest challenges facing the pharmaceutical industry today include changing patient expectations, increased self-medication, difficulties in identifying novel medicines for incurable diseases, high payer scrutiny of pharma-economic performance, the trend for governments to favour prevention over treatment, and access to emerging markets. Partnering with MI helps turn these challenges into opportunities.
           
          What we offer
          ✓ Development of clinical psychotherapy interventions for multiple indications and comorbidities
          ✓ Intervention delivery at scale via an engaging mobile platform
          ✓ Objective quantification of efficacy and mental wellbeing in real time, without the need for a wearable

          Rx + DTx pairing

          Improve efficacy & patient experience

           

          Accelerate market access & reimbursement

          Standalone DTx

          Generate compound-agnostic revenue

           

          Access actionable patient data

           

          Clinical endpoints

          Capture objective biometrics remotely

           

          Augment mental wellbeing assessment

        • Patient Testimonials

          "…it was helping me get through my post cancer treatments and my cancer that has been a very very rough journey."

          Breast cancer survivor (double mastectomy)

          "... this [digital therapeutic] forced me to block out the world and say okay, this moment is mine right now, and I'm going to enjoy this moment for myself."

          Testicular cancer survivor (chemotherapy)

          "…I felt like it was an actual meditation – like they were actually there with me."

          Kidney cancer survivor (immunotherapy)

        • Certifications

          Mobio Interactive’s digital therapeutic platform “AmDTx” is CE MDD Class I and DCB 0129 certified; GDPR-, HIPAA- and PHIPA-compliant; and undergoing certification for CE MDR Class IIa, ISO 13485, ISO 9000 and ISO 27001.

          Clinical Trials

          Validating the accuracy of our digital biomarkers and the efficacy of our digital theragnostic platform, AmDTx.

        CONTACT US

        TERMS OF USE

        PRIVACY POLICY

        Effective and accessible healthcare for every human.

          All Posts
          ×
          Cookie Use
          We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
          Learn More